Market Value to Book Value Ratio: vivani.com (VANI)

vivani.com - graphic logo of issuer VANI

Vivani Medical, Inc. (VANI) is currently in the research phase, meaning its current pricing power stands at 5.36. The price action on GURU.Markets reflects the dynamics of the company, which develops miniature subcutaneous systems for the gradual release of diabetes medications. The business relies on partnerships with biolabs to develop long-term therapies for metabolic disorders via high-tech implants.

vivani.com (VANI) Market Capitalization to Net Assets: for the period 04/28/2023 - 10/29/2026
Flagship merchandise of Vivani Medical, Inc.

This ratio determines the gap between the market valuation of the business and the value of its tangible assets. It compares market value to book value, revealing the investment's margin of safety. By analyzing the historical relationship between market capitalization and book value, one can determine the risk of overvaluation or undervaluation of the issuer. For Vivani Medical, Inc. (VANI), this balance is critical when capitalizing costs for eco-friendly implants. The efficiency of replacing injections with long-term devices directly impacts the future value of net assets.

Competitor analysis

BSX: Market Capitalization to Book Value Ratio|EW - Market Capitalization to Book Value|Market Value to Book Value Ratio ResMed|Insulet Corp (PODD) - Market Capitalization to Book Value|Market Value to Book Value Ratio Zimmer Biomet Holdings, Inc. (ZBH)|COO: Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio ALGN (Align Technology, Inc.)|globusmedical.com (GMED) - Market-to-Book Ratio|TransMedics Group - Market Capitalization to Book Value Ratio|Alphatec Holdings (ATEC) - Market Cap to Net Assets Ratio|AORT: Market Capitalization to Book Value Ratio|ENOV - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio establishmentlabs.com|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRMD (IRADIMED Corp)|Market Capitalization to Book Value Ratio EMBC (Embecta Inc.)|Market Capitalization to Book Value Tandem Corp (TNDM)|AXGN: Market Cap to Net Assets Ratio|Market Capitalization to Net Assets SIBN|OFIX: Market Capitalization to Book Value Ratio|Market-to-Book Ratio Bioventus Inc (BVS)|KIDS (OrthoPediatrics Corp) - Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio TMCI (Treace Corp)|Market Cap to Net Assets Ratio SRTA (Strata Critical Medical Inc)|CARL (carlsmed.com) - Market Value to Book Value|Market Value to Book Value Ratio RxSight RXST|CLPT - Market Cap to Net Assets Ratio|Stereotaxis Corp - Market Capitalization to Book Value Ratio|Market-to-Book Ratio Neuronetics, Inc|SGHT: Market Capitalization to Book Value Ratio|Capitalization to Book Value Ratio OBIO|ANIK (Anika Therapeutics Inc.) - Market Capitalization to Book Value Ratio|InspireMD Inc (NSPR) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ZJYL|Market Cap to Net Assets Ratio xtantmedical.com XTNT|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Market Capitalization to Book Value Ratio Modular Medical Inc MODD|MYO - Market Value to Book Value Ratio|COCH: Market Value to Book Value Ratio|VVOS (Vivos Therapeutics, Inc) - Market Cap to Net Assets Ratio|enVVeno Corp - Market Value to Book Value|SINT (Sintx Technologies Inc) - Market Capitalization to Book Value Ratio|Market-to-Book Ratio tenonmed.com TNON|Market Value to Book Value Ratio Lifeward (LFWD)|autonomix.com (AMIX) - Market Value to Equity Ratio|INVO Bioscience, Inc. - Market Cap to Net Assets Ratio|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Axonics, Inc. - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value biolase.com BIOL|dynatronics.com (DYNT) - Market Value to Book Value Ratio|Market Capitalization to Net Assets FNA (Paragon 28)|Market Value to Book Value Ratio INVO Bioscience Inc.